203 related articles for article (PubMed ID: 22117551)
21. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.
Spiegelman VS; Budunova IV; Carbajal S; Slaga TJ
Mol Carcinog; 1997 Sep; 20(1):99-107. PubMed ID: 9328440
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells.
Rauner M; Goettsch C; Stein N; Thiele S; Bornhaeuser M; De Bosscher K; Haegeman G; Tuckermann J; Hofbauer LC
Endocrinology; 2011 Jan; 152(1):103-12. PubMed ID: 21084452
[TBL] [Abstract][Full Text] [Related]
23. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
Denlinger CE; Rundall BK; Jones DR
J Thorac Cardiovasc Surg; 2004 Nov; 128(5):740-8. PubMed ID: 15514602
[TBL] [Abstract][Full Text] [Related]
24. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
25. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression.
Zhao Q; Pang J; Favata MF; Trzaskos JM
Int Immunopharmacol; 2003 Dec; 3(13-14):1803-17. PubMed ID: 14636830
[TBL] [Abstract][Full Text] [Related]
26. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
Clarisse D; Van Wesemael K; Tavernier J; Offner F; Beck IM; De Bosscher K
PLoS One; 2018; 13(5):e0197000. PubMed ID: 29738549
[TBL] [Abstract][Full Text] [Related]
27. Sequence-specific transcription factors during glucocorticoid-induced apoptosis in acute lymphoblastic leukemia cells.
Hartmann BL; Geley S; Kofler R
Wien Klin Wochenschr; 1999 May; 111(9):360-7. PubMed ID: 10407997
[TBL] [Abstract][Full Text] [Related]
28. The effects of proteasome inhibitor bortezomib on a P-gp positive leukemia cell line K562/A02.
Lü S; Chen Z; Yang J; Chen L; Zhou H; Xu X; Li J; Han F; Wang J
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e123-31. PubMed ID: 19254348
[TBL] [Abstract][Full Text] [Related]
29. Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells.
Psarra AM; Hermann S; Panayotou G; Spyrou G
Biochem J; 2009 Aug; 422(3):521-31. PubMed ID: 19570036
[TBL] [Abstract][Full Text] [Related]
30. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
31. The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages.
Mylka V; Deckers J; Ratman D; De Cauwer L; Thommis J; De Rycke R; Impens F; Libert C; Tavernier J; Vanden Berghe W; Gevaert K; De Bosscher K
Autophagy; 2018; 14(12):2049-2064. PubMed ID: 30215534
[TBL] [Abstract][Full Text] [Related]
32. Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.
Lesovaya E; Yemelyanov A; Swart AC; Swart P; Haegeman G; Budunova I
Oncotarget; 2015 Oct; 6(31):30730-44. PubMed ID: 26436695
[TBL] [Abstract][Full Text] [Related]
33. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
[TBL] [Abstract][Full Text] [Related]
34. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD
J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154
[TBL] [Abstract][Full Text] [Related]
35. Differential nuclear localisation and promoter occupancy play a role in glucocorticoid receptor ligand-specific transcriptional responses.
Hadley KE; Louw A; Hapgood JP
Steroids; 2011; 76(10-11):1176-84. PubMed ID: 21641918
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells.
Dvorák Z; Vrzal R; Maurel P; Ulrichová J
Chem Biol Interact; 2006 Feb; 159(2):117-28. PubMed ID: 16289013
[TBL] [Abstract][Full Text] [Related]
38. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells.
Dai Y; Chen S; Kramer LB; Funk VL; Dent P; Grant S
Clin Cancer Res; 2008 Jan; 14(2):549-58. PubMed ID: 18223231
[TBL] [Abstract][Full Text] [Related]
39. Elevated glucocorticoid receptor binding in cultured human lymphoblasts following hydroxyurea treatment: lack of effect on steroid responsiveness.
Littlefield BA; Hoagland HC; Greipp PR
Cancer Res; 1986 Aug; 46(8):3945-50. PubMed ID: 3731065
[TBL] [Abstract][Full Text] [Related]
40. Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.
An J; Sun YP; Adams J; Fisher M; Belldegrun A; Rettig MB
Clin Cancer Res; 2003 Oct; 9(12):4537-45. PubMed ID: 14555528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
